The framework balances two equal goals: - Preventing organ dysfunction in those without complications by targeting fat mass accumulation - Reversing organ dysfunction in patients with complications such as type 2 diabetes, cardiovascular disease, MASLD, heart failure, or osteoarthritis This approach positions obesity treatment as disease modification, emphasizing protection of the heart, liver, pancreas, joints, and lungs beyond weight reduction alone EASO Framework: #EASO #Tirzepatide #Semaglutide #GLP1RAs #Getzpharma To view or add a comment, sign in Chronic kidney disease (CKD) is highly heterogeneous with different etiologies and mechanisms believed to underlie diabetic kidney disease (DKD), glomerulonephritis (GN), and hypertensive nephropathy (HTN)
The dose escalation phase (weeks 416, depending on the specific medication) involves gradually increasing the dose according to the prescribed schedule
Now I feel sexy and confident, said Svensson, whos no longer shy about having sex with hubby Erik
Clinical Efficacy: What the Evidence Shows Head-to-head trials and observational data reveal meaningful differences in weight loss outcomes
Consult with your healthcare provider if you want to stop the medications
It possesses well-defined anti-inflammatory properties, which can mitigate the systemic inflammatory response by inhibiting the release of inflammatory cytokines, thereby reducing inflammatory damage and aiding patient recovery